Camrelizumab and Chemotherapy Combined With Endoscopic Surgery for Recurrent Nasopharyngeal Carcinoma
Conditions
- Recurrent Nasopharyngeal Carcinoma
Interventions
- DRUG: Camrelizumab
- DRUG: Chemotherapy
- PROCEDURE: endoscopic surgery
Sponsor
Eye & ENT Hospital of Fudan University
Collaborators